• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Pituitary and Skull Base Tumor Program

UCLA Pituitary and Skull Base Tumor Program

UCLA Pituitary and Skull Base Tumor Program
  • About Us
    • Why Choose UCLA
    • UCLA Neurosurgery
    • In the News
  • Pituitary Tumor Conditions
    • Pituitary Adenomas
    • Craniopharyngioma
    • Rathke's Cleft Cyst
  • Treatments Offered
    • Endoscopic Pituitary Surgery
    • Endoscopic Skull Base Surgery
    • Minimally-invasive Craniotomy
    • Hormone Testing
    • Focused Radiation Therapy
  • For Patients
    • Request An Appointment
    • Request Medical Records
    • Patient Story
    • Resources and Links
    • Clinical Trials
  • For Healthcare Professionals
    • Referring a Patient
    • VIDEOS: Expert Lecture Series
    • VIDEOS: Pituitary iCases
    • Conferences and Courses
  • FAQs
    • Video FAQs
  • Contact Us
  • Our Expert Team
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Pituitary and Skull Base Tumor Program

Treatments Offered

Treatments Offered

Treatments Offered

  • Endoscopic Pituitary Surgery
  • Endoscopic Skull Base Surgery
  • Minimally-invasive Craniotomy
  • Hormone Testing
    • Additional Pituitary Function Testing
  • Focused Radiation Therapy
  • Endoscopic Pituitary Surgery
  • Endoscopic Skull Base Surgery
  • Minimally-invasive Craniotomy
  • Hormone Testing
  • Focused Radiation Therapy
  • Additional Pituitary Function Testing
  1. Home
  2. Treatments Offered
  3. Hormone Testing
  4. Additional Pituitary Function Testing

Additional Pituitary Function Testing

Share this

Pituitary Tumor & Neuroendocrine Disorders

Pituitary hormones are released in pulses, levels fluctuate during the day, and the release of one hormone directly affects the release of others. For these reasons, a single blood test often is not sufficient to determine the nature and extent of a specific type of pituitary deficiency. Effective assessment tests include the following:

Cortrosyn Stimulation Test

  • Adrenocorticotropic hormone (ACTH) is injected to stimulate the adrenal glands and blood cortisol level is checked 60 minutes later.
  • When pituitary disease impairs ACTH production, the adrenal glands lose their capacity to secrete cortisol in response to stimulation.

Metyrapone Test

  • This test also assesses pituitary ACTH hormones. Twelve tablets (3 grams) of metyrapone are given to the patient at bedtime and blood is drawn the following morning to check ACTH levels.
  • Since metyrapone blocks adrenal hormone production, normal individuals respond by producing large amounts of ACTH. Lack of response indicates pituitary disease affecting ACTH production.

Insulin Tolerance Test

  • In this test, insulin is injected to lower blood sugars (hypoglycemia).
  • The normal response to hypoglycemia is release of ACTH and growth hormone (GH), which counteracts low blood sugars. Patients deficient in GH and ACTH fail show no hormonal response to hypoglycemia.

 

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest